Product Information
LORAZEPAM 1 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0365 per EA under NDC 13107008499. Its NADAC has been published 223 times since Mar 23, 2022.
Strength
1 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107008499
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203572On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 1 MG TABLET has been published 223 times since Mar 23, 2022, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0365 per EA |
|---|---|
| All-time high | $0.0559 (Apr 10, 2024) |
| All-time low | $0.0341 (Nov 20, 2024) |
| 52-week high | $0.0500 |
| 52-week low | $0.0364 |
| Median price | $0.0432 |
| Average price | $0.0445 |
| Largest weekly change | -32.4% (Nov 20, 2024) |
| Weeks tracked | 223 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 1 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0365 per EA (NDC 13107008499), effective Jun 24, 2026.
How has the price of LORAZEPAM 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 1 MG TABLET has declined 20.4%. It has been tracked across 223 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 1 MG TABLET?
Since Mar 23, 2022, the NADAC for LORAZEPAM 1 MG TABLET has ranged from a low of $0.0341 (Nov 20, 2024) to a high of $0.0559 (Apr 10, 2024), with a median of $0.0432 per EA.
Are there cheaper alternatives to LORAZEPAM 1 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LORAZEPAM 1 MG TABLET, but none are currently priced below it.
Who manufactures LORAZEPAM 1 MG TABLET?
LORAZEPAM 1 MG TABLET (NDC 13107008499) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification